메뉴 건너뛰기




Volumn 71, Issue 9, 2016, Pages 2559-2562

Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFTRIAXONE;

EID: 85013350957     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw180     Document Type: Article
Times cited : (16)

References (18)
  • 1
    • 3343012046 scopus 로고    scopus 로고
    • Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones
    • Ito M, Yasuda M, Yokoi S et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48: 3185-7.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 3185-3187
    • Ito, M1    Yasuda, M2    Yokoi, S3
  • 2
    • 84933049453 scopus 로고    scopus 로고
    • The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013
    • Hamasuna R, Yasuda M, Ishikawa K et al. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013. J Infect Chemother 2015; 21: 340-5.
    • (2015) J Infect Chemother , vol.21 , pp. 340-345
    • Hamasuna, R1    Yasuda, M2    Ishikawa, K3
  • 3
    • 84870998337 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of sexually transmitted diseases 2011
    • Japanese Society for Sexually Transmitted Diseases. Suppl
    • Japanese Society for Sexually Transmitted Diseases. Guidelines for the diagnosis and treatment of sexually transmitted diseases 2011. Jpn J Sex Transm Dis 2011; 22 Suppl: 52-9.
    • (2011) Jpn J Sex Transm Dis , vol.22 , pp. 52-59
  • 4
    • 51349130594 scopus 로고    scopus 로고
    • Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae
    • Muratani T, Inatomi H, Ando Y et al. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae. Int J Urol 2008; 15: 837-42.
    • (2008) Int J Urol , vol.15 , pp. 837-842
    • Muratani, T1    Inatomi, H2    Ando, Y3
  • 5
    • 84930940449 scopus 로고    scopus 로고
    • Sexually transmitted diseases treatment guidelines, 2015
    • CDC. RR-03
    • Workowski KA, Bolan GA; CDC. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 RR-03: 1-137.
    • (2015) MMWR Recomm Rep , vol.64 , pp. 1-137
    • Workowski, KA1    Bolan, GA2
  • 6
    • 84879495636 scopus 로고    scopus 로고
    • 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
    • European STI Guidelines Editorial Board
    • Bignell C, Unemo M; European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 2013; 24: 85-92.
    • (2013) Int J STD AIDS , vol.24 , pp. 85-92
    • Bignell, C1    Unemo, M2
  • 8
    • 79959189164 scopus 로고    scopus 로고
    • Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone
    • Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 3538-3545
    • Ohnishi, M1    Golparian, D2    Shimuta, K3
  • 9
    • 84939529739 scopus 로고    scopus 로고
    • Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge
    • Unemo M. Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 2015; 15: 364.
    • (2015) BMC Infect Dis , vol.15 , pp. 364
    • Unemo, M.1
  • 10
    • 84950273190 scopus 로고    scopus 로고
    • New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan
    • Deguchi T, Yasuda M, Hatazaki K et al. New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan. Emerg Infect Dis 2016; 22: 142-4.
    • (2016) Emerg Infect Dis , vol.22 , pp. 142-144
    • Deguchi, T1    Yasuda, M2    Hatazaki, K3
  • 11
    • 85013271556 scopus 로고    scopus 로고
    • Novel penA mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan
    • Seike K, Yasuda M, Hatazaki K et al. Novel penA mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan. J Antimicrob Chemother 2016; 71: 2466-70.
    • (2016) J Antimicrob Chemother , vol.71 , pp. 2466-2470
    • Seike, K1    Yasuda, M2    Hatazaki, K3
  • 12
    • 80052845543 scopus 로고    scopus 로고
    • Japanese guideline for clinical research of antimicrobial agents on urogenital infections: the first edition
    • Yasuda M, Takahashi S, Kiyota H et al. Japanese guideline for clinical research of antimicrobial agents on urogenital infections: the first edition. J Infect Chemother 2011; 17: 579-94.
    • (2011) J Infect Chemother , vol.17 , pp. 579-594
    • Yasuda, M1    Takahashi, S2    Kiyota, H3
  • 15
    • 0028940924 scopus 로고
    • Drugs of choice for the treatment of uncomplicated gonococcal infections
    • Suppl 1
    • Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis 1995; 20 Suppl 1: S47-65.
    • (1995) Clin Infect Dis , vol.20 , pp. S47-S65
    • Moran, JS1    Levine, WC.2
  • 17
    • 77957231790 scopus 로고    scopus 로고
    • Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
    • Chisholm SA, Mouton JW, Lewis DA et al. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother 2010; 65: 2141-8.
    • (2010) J Antimicrob Chemother , vol.65 , pp. 2141-2148
    • Chisholm, SA1    Mouton, JW2    Lewis, DA3
  • 18
    • 84900500899 scopus 로고    scopus 로고
    • In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae
    • Barbee LA, Soge OO, Holmes KK et al. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae. J Antimicrob Chemother 2014; 69: 1572-8.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 1572-1578
    • Barbee, LA1    Soge, OO2    Holmes, KK3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.